TOBAF - TAAT Global Alternatives, Inc. Completes Acquisition of Premium Products LLC
(TheNewswire)
Vancouver, BC – TheNewswire - February 21, 2025 – TAAT Global Alternatives, Inc. ( CSE: TAAT )( OTCQX: TOBAF ) ( FRANKFURT:2TP ) (the “Company” or “TAAT”) ispleased to announce that, further to its news release dated January27, 2025, it has closed the acquisition of Premium Products LLC(“Premium Products”).
As consideration for the acquisition of all theoutstanding shares of Premium Products, the Company issued anaggregate of 10,882,353 common shares (“Consideration Shares”) ofTAAT, at a deemed price of $0.17 per share to the members of PremiumProducts.
The Consideration Shares are subject to a hold periodof four months and one day from the date of issuance, in accordancewith the National Instrument45-106 (Prospectus Exemptions) and the followingresale restrictions as set out by the Canadian Securities Exchange(the “CSE”):
i. 25% of the securities will bereleased upon the filing of the Company’s next financial statementsthat include Premium Products on the balance sheet; and
ii. the remaining 75%of the securities will be released in 25% increments for each CDN$500,000 in revenue generated by Premium Products, up to a total ofCDN $1,500,000, as reflected in the Company’s audited financialstatements.
No finders’ fees payable were payable on thistransaction, nor was there a change of control or any new controlpersons created. The acquisition did constitute a fundamental change,within the meaning of the policies of the CSE.
None of the securities issued in connection with theacquisition of Premium Products have been registered under the UnitedStates Securities Act of 1933, as amended (the “1933 Act”), andnone of them will be offered or sold in the United States absentregistration or an applicable exemption from the registrationrequirements of the 1933 Act. This news release shall not constitutean offer to sell or a solicitation of an offer to buy nor shall therebe any sale of the securities in any state where such offer,solicitation, or sale would be unlawful.
On behalf of the Board of Directors of theCompany,
TAAT® GLOBAL ALTERNATIVES INC.
“Joel Dumaresq”
Joel Dumaresq, CFO and Director
For further information, please contact:
TAAT® Investor Relations
1-604-687-2038
investor@taatglobal.com
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOTREVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY ORADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATIONSERVICES PROVIDER.
AboutTAAT Global Alternatives, Inc.
TAAT is a consumer product company specializing ininnovative alternatives to traditional CPG categories. With acommitment to quality and consumer satisfaction, TAAT operates fromits Ohio distribution center, fulfilling orders and supporting agrowing network of retail locations across the U.S.
For additional information, visit taatglobal.com
Forward-Looking Statements
Certain information contained herein may constitute"forward-looking information" or "forward-lookingstatements" under Canadian securities legislation. Generally,forward-looking information can be identified by words such as"pro forma", "plans", "expects","may", "should", "could","will", "budget", "scheduled","estimates", "forecasts", "intends","anticipates", "believes", or variations includingnegative variations thereof of such words and phrases that refer tocertain actions, events or results that may, occur or be taken orachieved. Such forward-looking statements, including but not limitedto statements relating to the expected development and operations ofthe Company, including market conditions, regulatory developments andthe successful integration and performance of Premium Products LLCwithin TAAT’s broader operations which involve risks,uncertainties and other factors which may cause the actual results tobe materially different from those expressed or implied by suchforward-looking statements or forward-looking information. There canbe no assurance that such statements will prove to be accurate, asactual results and future events could differ materially from thoseanticipated in such statements. Accordingly, readers should not placeundue reliance on forward-looking statements and forward-lookinginformation. The Corporation will not update any forward-lookingstatements or forward-looking information included herein, except asrequired by applicable securities laws.
The statements in this news release have not beenevaluated by Health Canada or the U.S. Food and Drug Administration.As each individual is different, the benefits, if any, of taking theCompany’s products will vary from person to person. No claims orguarantees can be made as to the effects of the Company’s productson an individual’s health and well-being. The Company’s productsare not intended to diagnose, treat, cure, or prevent anydisease.
This news release may contain trademarked names ofthird-party entities (or their respective offerings with trademarkednames) typically in reference to (i) relationships had by the Companywith such third-party entities as referred to in this release and/or(ii) client/vendor/service provider parties whose relationship withthe Company is/are referred to in this release. All rights to suchtrademarks are reserved by their respective owners orlicensees.
Statement Regarding Third-PartyInvestor Relations Firms
Disclosures relating to investor relations firmsretained by TAAT® Global Alternatives Inc. can be found under theCompany's profile on www.sedarplus.ca .
Copyright (c) 2025 TheNewswire - All rights reserved.